$341 Million is the total value of Bracebridge Capital, LLC's 12 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 38.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ISHARES TRcall | $246,901,000 | – | 3,025,000 | +100.0% | 72.30% | – | |
| LIBERTY MEDIA CORPdeb | $34,158,000 | +31.4% | 47,700,000 | 0.0% | 10.00% | +112.2% | ||
| DISH NETWORK CORPORATIONnote | $18,904,000 | +35.0% | 20,300,000 | 0.0% | 5.54% | +118.0% | ||
| DISH | Sell | DISH NETWORK CORPORATIONcl a | $12,941,000 | +43.8% | 375,000 | -6.2% | 3.79% | +132.2% |
| LIBERTY MEDIA CORPdeb | $6,690,000 | +33.8% | 9,500,000 | 0.0% | 1.96% | +116.0% | ||
| New | DINE BRANDS GLOBAL INCput | $5,473,000 | – | 130,000 | +100.0% | 1.60% | – | |
| TEVA PHARMACEUTICAL FIN LLCdbcv | $5,404,000 | +8.1% | 5,500,000 | 0.0% | 1.58% | +74.5% | ||
| NLSN | Sell | NIELSEN HLDGS PLC | $4,458,000 | -36.3% | 300,000 | -43.4% | 1.31% | +2.9% |
| AMBC | AMBAC FINL GROUP INC | $2,854,000 | -4.9% | 199,300 | 0.0% | 0.84% | +53.7% | |
| AQST | AQUESTIVE THERAPEUTICS INC | $2,083,000 | +108.3% | 428,571 | 0.0% | 0.61% | +237.0% | |
| CHESAPEAKE ENERGY CORPnote | $822,000 | -17.8% | 23,475,000 | 0.0% | 0.24% | +33.1% | ||
| CCO | CLEAR CHANNEL OUTDOOR HLDGS | $787,000 | +57.4% | 756,426 | 0.0% | 0.23% | +152.7% | |
| HYG | Exit | ISHARES TRiboxx hi yd etf | $0 | – | -26,591 | -100.0% | -0.36% | – |
| HYG | Exit | ISHARES TRcall | $0 | – | -1,500,000 | -100.0% | -21.03% | – |
| HYG | Exit | ISHARES TRput | $0 | – | -4,650,000 | -100.0% | -65.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIBERTY MEDIA CORP DEL | 16 | Q3 2023 | 10.0% |
| AMBAC FINL GROUP INC | 16 | Q3 2023 | 6.2% |
| AQUESTIVE THERAPEUTICS INC | 16 | Q3 2023 | 0.6% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 0.6% |
| DISH NETWORK CORPORATION | 11 | Q2 2022 | 5.5% |
| ISHARES TR | 10 | Q3 2023 | 65.7% |
| ISHARES TR | 10 | Q3 2023 | 72.3% |
| COMPUTE HEALTH ACQUISITIN CO | 10 | Q2 2023 | 0.6% |
| CHURCHILL CAPITAL CORP VII | 9 | Q1 2023 | 0.3% |
| CHURCHILL CAPITAL CORP VI | 9 | Q1 2023 | 0.1% |
View Bracebridge Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Quotient Ltd | February 22, 2023 | 62,030 | 0.3% |
| Clarus Therapeutics Holdings, Inc. | July 06, 2022 | 1,461,822 | 2.8% |
| PERNIX THERAPEUTICS HOLDINGS, INC.Sold out | May 26, 2016 | 0 | 0.0% |
View Bracebridge Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-08 |
| SC 13D/A | 2023-11-17 |
| 4 | 2023-11-16 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-08-25 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-08-04 |
| SC 13D | 2023-06-16 |
| SC 13G | 2023-06-15 |
View Bracebridge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.